People

Tom Golisano is venture advisor at Impellent Ventures. The firm's public network lists an advisory affiliation; outside employment is separate.

Montinique Kniffen is operations at Impellent Ventures.

Tariq Trotter is team member at Impellent Ventures.

Phil Beauregard is manager at Impellent Ventures.

David Brown is founder, ceo & manager at Impellent Ventures.

Hydrogen and fuel-cell technology specialist, formerly leading electrolysis and hydrogen production programs at the US Department of Energy; technical adviser to Teragen Energy.

Matt Jacobson: Director Of Investor Relations at Blue Heron Capital.

Nick Graziano: Principal at Blue Heron Capital.

Laura Tizard: Accounting Manager at Blue Heron Capital.

Kevin Musco: Vice President at Blue Heron Capital.

Christine Lane: Controller at Blue Heron Capital.

Jim Riley: Operating Partner at Blue Heron Capital.

Andrew Tichenor: Co-Founder & Managing Partner at Blue Heron Capital.

Tom Benedetti: Co-Founder & Managing Partner at Blue Heron Capital.

Ryan McNally: Senior Advisor at Catalyst Investors.

Lindsey Brown: Office Administrator at Catalyst Investors.

Jamie Ku: Controller at Catalyst Investors.

Natalie Hallagan: Associate, Business Development at Catalyst Investors.

Jay Sidhu: Associate at Catalyst Investors.

Jack O'Brien: Associate at Catalyst Investors.

Annie Veldman: Senior Associate at Catalyst Investors.

Killian Bubrosky: Senior Associate at Catalyst Investors.

Sidney Kullar: Principal at Catalyst Investors.

John Buck: Principal at Catalyst Investors.

Kapil Desai: Partner at Catalyst Investors.

Tyler Newton: Managing Partner at Catalyst Investors.

Brian Rich: Managing Partner & Founder at Catalyst Investors.

Kayla Fermoile: Partner Services Manager at Ognomy Sleep.

Karen Casalinuovo: Administrative Manager at Ognomy Sleep.

Marissa Otto: Digital Marketing Specialist at Ognomy Sleep.

Tannay Chandhok: Chief Technology Officer at Ognomy Sleep.

Linda Anegawa: Chief Medical Officer at Ognomy Sleep.

Pete Grandits: Chief Financial Officer at Ognomy Sleep.

June Seliber-Klein: Chief of Sleep Medicine at Ognomy Sleep.

Ken Rosenfeld: Chief Operating Officer at Ognomy Sleep.

Daniel Rifkin: Founder, President and Chief Executive Officer at Ognomy Sleep.

Michael Carrel serves as Director at Inspire Medical Systems.

Myriam Curet serves as Director at Inspire Medical Systems. Myriam Curet is listed by Mobia Medical (formerly MicroTransponder) as Board Member. She retired as Intuitive Surgical’s executive vice president and chief medical officer in March 2026 and remains a Stanford clinical professor. Her Mobia board appointment was announced July 30, 2026.

Shelley Broader serves as Director at Inspire Medical Systems.

Shawn McCormick serves as Director at Inspire Medical Systems. Shawn McCormick is published by Vensana Capital as Advisor (published professional affiliation). Medtech industry advisor whose source-published professional experience includes Aldevron, Tornier, Lutonix. These outside-company titles summarize published experience and are not independently asserted current offices, Vensana employment, company directorships or personal cash investments.

Cynthia Burks serves as Director at Inspire Medical Systems.

Dana Mead Jr. serves as Director at Inspire Medical Systems. Dana G. Mead, Jr. is listed by Mobia Medical (formerly MicroTransponder) as Chairman of the Board. His healthcare operating and investing experience includes HeartFlow, BVI, Kleiner Perkins and Guidant.

Georgia Melenikiotou serves as Director at Inspire Medical Systems.

Gary Ellis serves as Director at Inspire Medical Systems.

Joe Sander serves as Senior Vice President, U.S. Sales at Inspire Medical Systems.

Andreas Henke serves as Executive Vice President, International and Managing Director at Inspire Medical Systems.

Melissa Mann serves as Chief People Officer at Inspire Medical Systems.

Bryan Phillips serves as Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary at Inspire Medical Systems.

Jason Kelly serves as Chief Operations and Innovation Officer at Inspire Medical Systems.

Carlton Weatherby serves as Chief Strategy and Growth Officer at Inspire Medical Systems.

Matt Osberg serves as Chief Financial Officer at Inspire Medical Systems.

Tim Herbert serves as Founder, Chairman, President and Chief Executive Officer at Inspire Medical Systems.

President of Tohoku University Venture Partners since February 2026. Joined THVP in September 2025 after 34 years at Sumitomo Mitsui Banking Corporation and six years as president of SMBC Human Career, working on corporate banking, private advisory, human resources and executive recruitment.

Shaheen Hamdy co-founded Phagenesis and is its chief scientific officer. A University of Manchester professor of neurogastroenterology, his research studies neuroplasticity and recovery of swallowing control after brain injury.

Ceara Chambers: Executive Assistant, Questa Capital.

Sara Tate: Executive Assistant, Questa Capital.

Julia Iglesias: Associate, Questa Capital.

Michael Davis: Associate, Questa Capital.

Jonathan Li: Associate, Questa Capital.

Chandler Lally: Vice President, Questa Capital.

Eric Thakor: Vice President, Questa Capital.

Evans Grenier: Vice President, Questa Capital.

Steph Scott: Vice President, Questa Capital.

Joe Huang: Chief Financial Officer, Questa Capital.

Justin Kirkpatrick: Partner, Questa Capital.

Shawn Conway: Managing Partner and COO, Questa Capital.

Bradley Sloan: Managing Partner, Questa Capital.

Brian Butler: Director, EnsoData.

John Rondoni: Director, EnsoData.

Angela Becker-Bradley: Human Resources Manager, EnsoData.

Rachel Boer: Senior Marketing Director, EnsoData.

Cameron Brackett: Vice President of Engineering, EnsoData.

Kelsey Buehl: Vice President of Customer Success, EnsoData.

Sigrid Schoepel: Vice President of Quality and Regulatory, EnsoData.

Yoav Nygate: Vice President of Artificial Intelligence, EnsoData.

Joe Austin: Senior Vice President of Global Business Development, EnsoData.

Fred Turkington: Senior Vice President of Product Management, EnsoData.

Bobby Cockrill: Chief Commercial Officer, EnsoData.

Matt Dobereiner: Chief Financial Officer, EnsoData.

Nathaniel Watson: Chief Medical Officer, EnsoData.

Brock Hensen: Chief Operating Officer, EnsoData.

Nick Glattard: Co-Founder and Chief Technology Officer, EnsoData.

Sam Rusk: Co-Founder and Chief AI Officer, EnsoData.

Chris Fernandez: Co-Founder, Executive Chairman and Chief Research Officer, EnsoData.

Linda Olson: Office Manager, Clarevia Ventures.

Becky Hoerman: Controller, Clarevia Ventures.

Shelly Lanning: Venture Partner, Clarevia Ventures.

Cheryl R. Blanchard: Executive in Residence, Clarevia Ventures.

Margaret Kaczor Andrew: Venture Partner, Clarevia Ventures.

Jenni Le: Principal, Clarevia Ventures.

Joe Amaral: Chief Medical and Scientific Officer, Clarevia Ventures.

John Neis: Partner, Clarevia Ventures.

David Arnstein: Partner and CFO, Clarevia Ventures.

Paul Weiss: Partner, Clarevia Ventures.

Scott Button: Partner, Clarevia Ventures.

Maria Kousi: Director, EarliPoint Health.

Jim Adox: Director, EarliPoint Health.

Jim Grien: Director, EarliPoint Health.

Mike Vassar: Director of Sales, EarliPoint Health.

Robin Sifre: Director of R&D, EarliPoint Health.

Ella Swanson-Hysell: Director of Product Management and Innovation, EarliPoint Health.

Ryan Bormann: Director of Operations and Quality, EarliPoint Health.

Christopher MacAloon: Executive Vice President of Operations, EarliPoint Health.

Pete Polgar: Vice President of Marketing, EarliPoint Health.

Leota Pearson: Chief Financial Officer, EarliPoint Health.

Cheryl Tierney: Chief Medical Officer, EarliPoint Health.

Ami Klin: Scientific Founder and Chief Clinical Officer, EarliPoint Health.

Warren Jones: Scientific Founder, EarliPoint Health.

Jamie Pagliaro: President, CEO and Director, EarliPoint Health.

Pharmaceutical-sciences doctorate; invests in Taiwanese life-sciences companies.

Taiwan-based biotech investor with a legal background.

Japan–Taiwan biotech investor based in Taiwan since 2008.

Biological-sciences graduate specializing in protein function; joined in 2024.

Joined DCI Partners in 2017 following private-equity work.

Pharmacist with pharmaceutical business-development experience.

Former Daiwa Securities M&A adviser; joined DCI Partners in 2015.

Pharmaceutical R&D planning background; joined DCI Partners in 2018.

Supports business planning and management of fund-created biotech companies.

DCI Partners co-founder investing in Japanese and Taiwanese biotech.

Biotech investor and founder of DCI Partners.

Lucas Harrington is a member of the SciFounders team and cofounder of Mammoth Biosciences. His SciFounders biography describes a UC Berkeley PhD in Jennifer Doudna's laboratory and incubation of Preventive, a company focused on preventing genetic diseases before birth.

Matt Krisiloff is a member of the SciFounders team and CEO of Conception, which is developing methods to turn pluripotent stem cells into viable human eggs. His SciFounders biography describes prior leadership of Y Combinator Research and experience helping science startups.

David M. Ratcliffe is listed by GRA Venture Fund as Director. The Fund's public leadership directory establishes this affiliation. Other employers described in the biography are separate affiliations.

Charles Ogburn is listed by GRA Venture Fund as Director. The Fund's public leadership directory establishes this affiliation. Other employers described in the biography are separate affiliations.

Bill Midgette is listed by GRA Venture Fund as Director. The Fund's public leadership directory establishes this affiliation. Other employers described in the biography are separate affiliations.

F. Duane Ackerman is listed by GRA Venture Fund as Director. The Fund's public leadership directory establishes this affiliation. Other employers described in the biography are separate affiliations.

Frances Gail Rogers is listed by GRA Venture Fund as Chair of the Board. The Fund's public leadership directory establishes this affiliation. Other employers described in the biography are separate affiliations.

Kurt Jacobus is listed by GRA Venture Fund as Senior Advisor. The Fund's public leadership directory establishes this affiliation. Other employers described in the biography are separate affiliations.

Connor Seabrook is listed by GRA Venture Fund as Managing Director. The Fund's public leadership directory establishes this affiliation. Other employers described in the biography are separate affiliations.

Biotech investor with research experience in neurological regenerative medicine.

Dementia Discovery Fund venture partner, also known as Tetsuyuki Maruyama; Alzheimer's Disease Data Initiative executive director and former Takeda drug discovery head.

Venture Partner at Fast Track Initiative since January 2015, overseeing HealthTech investments. Previously led Microsoft Japan’s healthcare business and worked in strategic business planning and pharmaceutical digital transformation at Bayer Japan; began his career at Mitsubishi Electric. Meiji University commerce graduate and MBA.

James Nahirny is publicly listed by BioCircuit Technologies as Director. This affiliation reflects the company's published board directory; continuation of an independent board after the October 2026 Axogen acquisition is not established by that listing.

Michelle Jarrard is publicly listed by BioCircuit Technologies as CEO and Director. This affiliation reflects the company's published board directory; continuation of an independent board after the October 2026 Axogen acquisition is not established by that listing.

Glenn H. Epstein is publicly listed by BioCircuit Technologies as Director. This affiliation reflects the company's published board directory; continuation of an independent board after the October 2026 Axogen acquisition is not established by that listing.

Thomas O'Brien is publicly listed by BioCircuit Technologies as Board Chair. This affiliation reflects the company's published board directory; continuation of an independent board after the October 2026 Axogen acquisition is not established by that listing.

Kathy Weiler is listed by Axogen as Director. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Joseph (Adrian) Tyndall is listed by Axogen as Director. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Alan M. Levine is listed by Axogen as Director. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

John H. Johnson is listed by Axogen as Director. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website. John Johnson is listed by HealthQuest Capital as Operating Partner. The primary biography explicitly identifies current Axogen board service and prior Strongbridge/ImClone leadership, matching existing John H. Johnson.

William Burke is listed by Axogen as Director. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Amy Wendell is listed by Axogen as Director. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Paul G. Thomas is listed by Axogen as Chairman of the Board. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Rick Ditto is listed by Axogen as VP, Global Health Economics, Reimbursement & Policy. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Jesse Bishop is listed by Axogen as Vice President of Regulatory. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Al Jacks is listed by Axogen as Vice President of Quality. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Amalia De Luca is listed by Axogen as Vice President of Planning and Business Development. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Stacy Arnold is listed by Axogen as Vice President of Product Development and Research. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Craig Swandal is listed by Axogen as Senior Vice President, Operations. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Erick DeVinney is listed by Axogen as Chief Scientific Officer. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Ivica Ducic is listed by Axogen as Chief Medical Officer. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Doris Quackenbush is listed by Axogen as Chief Revenue Officer. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Jens Schroeder Kemp is listed by Axogen as Chief Marketing Officer. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Lindsey Hartley is listed by Axogen as Chief Financial Officer. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Marc Began is listed by Axogen as Executive Vice President and General Counsel. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Michael Dale is listed by Axogen as President, Chief Executive Officer and Board Director. The company's public US leadership directory documents this affiliation; the portrait comes from its official international website.

Brynn Putnam is listed by The Venture Collective as Venture Partner. This role belongs to TVC's separately identified venture partner network.

Sanjiv Sanghavi is listed by The Venture Collective as Venture Partner. This role belongs to TVC's separately identified venture partner network.

Evan Segal is listed by The Venture Collective as Venture Partner. This role belongs to TVC's separately identified venture partner network.

Seanna Thompson is listed by The Venture Collective as Venture Partner. This role belongs to TVC's separately identified venture partner network.

Erica Dorfman is listed by The Venture Collective as Venture Partner. This role belongs to TVC's separately identified venture partner network. Erica Dorfman is published in Coalition Operators’ external operator network. Fintech exec who’s helped scale the companies reshaping how money moves. Published career affiliations: Brex, Tally, SoFi. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company.

James Gillespie is listed by The Venture Collective as Venture Partner. This role belongs to TVC's separately identified venture partner network.

Kristin Thayer is listed by The Venture Collective as Venture Partner. This role belongs to TVC's separately identified venture partner network.

Andrew Trader is listed by The Venture Collective as Venture Partner. This role belongs to TVC's separately identified venture partner network.

Paula Sutter is listed by The Venture Collective as Senior Advisor. This affiliation is documented in TVC's current public team directory.

Luke Lloyd-Davies is listed by The Venture Collective as Chairman. This affiliation is documented in TVC's current public team directory.

Chris Ghadban is listed by The Venture Collective as Principal. This affiliation is documented in TVC's current public team directory.

Cat Middleton is listed by The Venture Collective as General Partner. This affiliation is documented in TVC's current public team directory.

Elliot Richmond is listed by The Venture Collective as Senior Advisor. This affiliation is documented in TVC's current public team directory.

Emily Aronin is listed by The Venture Collective as Associate. This affiliation is documented in TVC's current public team directory.

Stephanie Sarelakos is listed by The Venture Collective as Partner. This affiliation is documented in TVC's current public team directory.

Gina Shekerdemian is listed by The Venture Collective as Founding Partner. This affiliation is documented in TVC's current public team directory.

Pete Ondishin is listed by The Venture Collective as Chief Financial Officer. This affiliation is documented in TVC's current public team directory.

Ines Ullmo is listed by The Venture Collective as Associate. This affiliation is documented in TVC's current public team directory.

Nicole Seligman is listed by The Venture Collective as Executive in Residence. This affiliation is documented in TVC's current public team directory.

Nicholas Shekerdemian is listed by The Venture Collective as Founding Partner. This affiliation is documented in TVC's current public team directory.

Harsh Sant is Research Associate at Trace Biosciences, which develops nerve-specific fluorescent imaging agents for surgery. The company's public team directory establishes this role.

Hanna Adler is Marketing and Research Associate at Trace Biosciences, which develops nerve-specific fluorescent imaging agents for surgery. The company's public team directory establishes this role.

Diego Jacho is Post Doctoral Scholar at Trace Biosciences, which develops nerve-specific fluorescent imaging agents for surgery. The company's public team directory establishes this role.

Ge Huang is Senior Research Associate at Trace Biosciences, which develops nerve-specific fluorescent imaging agents for surgery. The company's public team directory establishes this role.

Grace Hubbell is Staff Scientist at Trace Biosciences, which develops nerve-specific fluorescent imaging agents for surgery. The company's public team directory establishes this role.

Scott Houston is Head of Clinical Operations at Trace Biosciences, which develops nerve-specific fluorescent imaging agents for surgery. The company's public team directory establishes this role.

Veronica Torres is Clinical Project Manager at Trace Biosciences, which develops nerve-specific fluorescent imaging agents for surgery. The company's public team directory establishes this role.

Lawrence Trost is Head of Toxicology at Trace Biosciences, which develops nerve-specific fluorescent imaging agents for surgery. The company's public team directory establishes this role.

Mark Sorenson is Head of CMC Development at Trace Biosciences, which develops nerve-specific fluorescent imaging agents for surgery. The company's public team directory establishes this role.

Bryce Timm is Director of Research at Trace Biosciences, which develops nerve-specific fluorescent imaging agents for surgery. The company's public team directory establishes this role.

Lei Wang is Cofounder and Chief Technology Officer at Trace Biosciences, which develops nerve-specific fluorescent imaging agents for surgery. The company's public team directory establishes this role.

Summer Gibbs is Cofounder and Chief Scientific Officer at Trace Biosciences, which develops nerve-specific fluorescent imaging agents for surgery. The company's public team directory establishes this role.

Connor Barth is Cofounder and CEO at Trace Biosciences, which develops nerve-specific fluorescent imaging agents for surgery. The company's public team directory establishes this role.

Director of product at Mon Ami. This product professional is kept separate from the namesake Apellis chief financial officer.